Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases - 26/11/09
, Dievan Bisognin da Silva a, Aline M. Becker a, Marta M.M.F. Duarte c, Letícia L. Giovelli b, Sandra Huber da Silva b, Luana Rossato a, Maria B. Moretto a, b, José E. Paz da Silva a, b
Corresponding author. Universidade Federal de Santa Maria, Centro de Ciências da Saúde, Departamento de Análises Clínicas e Toxicológicas, Avenida Roraima 1000, Prédio 26, Sala 1216, Camobi, Santa Maria, RS 97105-900, Brazil. Tel.: +55 55 32208464; fax: +55 55 32208018.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Ischemia-modified albumin (IMA) has been shown to be a rapidly rising and sensitive biochemical marker for the diagnosis of myocardial ischemia. In this study, we evaluated the levels of IMA in myocardial infarction and prostate diseases, as well as the influence of HDL cholesterol levels on C-reactive protein (CRP) and IMA levels.
Methods |
A total of 27 patients with myocardial infarction (MI), 102 patients with benign prostatic hyperplasia (BPH), 84 patients with prostate cancer (PCA), and 21 healthy subjects were enrolled in this study. IMA levels were measured in whole studied patients. Cardiac troponin I (cTnI), cholesterol, HDL cholesterol, and CRP were measured in MI and control groups.
Results |
IMA values were significantly higher in patients with MI (0.5215±0.0241 ABSU) and BPH (0.4150±0.0156 ABSU) in comparison to control subjects (0.3381±0.0194 ABSU). IMA and CRP were higher in MI group, especially in patients with HDL cholesterol levels lower than 38mg/dL. The ability of IMA to discriminate myocardial infarction was higher than CRP. Significant correlations between CRP and HDL, CRP and IMA, and HDL and IMA were reported.
Conclusions |
IMA and CRP increase in myocardial damage, and the decrease of HDL cholesterol appears to enhance the inflammatory response. IMA also increase in benign prostate hyperplasia and this finding suggests that the diagnosis of prostate diseases must be considered on evaluation of IMA as a marker of cardiac ischemia.
Le texte complet de cet article est disponible en PDF.Keywords : Myocardial infarction, Prostate, Ischemia, Inflammation, Oxidative stress
Plan
Vol 63 - N° 10
P. 762-766 - décembre 2009 Retour au numéro
Article précédent
- Inhibition of renin–angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation
- Daiju Fukuda, Soichiro Enomoto, Ryozo Nagai, Masataka Sata
- Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure
- Ezequiel J. Molina, Jon Palma, Dipin Gupta, John P. Gaughan, Steven Houser, Mahender Macha
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?